Novakand Pharma AB (publ) (STO:NOVKAN)
Sweden · Delayed Price · Currency is SEK 0.0401
-0.0049 (-10.89%)
At close: Mar 27, 2026
Novakand Pharma AB Employees
Novakand Pharma AB had 5 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-9.45M SEK
Market Cap
4.86M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 5 | 0 | - |
| Dec 31, 2024 | 5 | 2 | 66.67% |
| Dec 31, 2023 | 3 | -2 | -40.00% |
| Dec 31, 2022 | 5 | -2 | -28.57% |
| Dec 31, 2021 | 7 | -1 | -12.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ExpreS2ion Biotech Holding AB | 20 |
| Nanologica AB | 19 |
| AcouSort AB | 16 |
| 2cureX AB | 14 |
| Guard Therapeutics International AB | 12 |
| Fluicell AB | 11 |
| Lipigon Pharmaceuticals AB | 7 |
| NanoEcho AB | 6 |